View Archive »
About The Cover
The cover for issue 98 of Oncotarget features Figure 7, "A working model: The payload (DM1)-mediated cytotoxicity," by Endo, et al.
|
|
Table of Contents
Editorial
|
| No equal opportunity for leukemia initiating cells |
|
https://doi.org/10.18632/oncotarget.26454
|
| 37078-37079 |
Research Papers
|
| A comparative pharmacokinetic study of PARP inhibitors demonstrates favorable properties for niraparib efficacy in preclinical tumor models |
|
https://doi.org/10.18632/oncotarget.26354
|
| 37080-37096 |
|
| Oncogenic transgelin2 is differentially regulated in isocitrate dehydrogenase wildtype vs mutant gliomas |
|
https://doi.org/10.18632/oncotarget.26365
|
| 37097-37111 |
|
| Detection of histone H3 K27M mutation and posttranslational modifications in pediatric diffuse midline glioma via tissue immunohistochemistry informs diagnosis and clinical outcomes |
|
https://doi.org/10.18632/oncotarget.26430
|
| 37112-37124 |
|
| Predicting clinically significant prostate cancer using DCEMRI habitat descriptors |
|
https://doi.org/10.18632/oncotarget.26437
|
| 37125-37136 |
|
| The molecular mechanism of action of methylene quinuclidinone and its effects on the structure of p53 mutants |
|
https://doi.org/10.18632/oncotarget.26440
|
| 37137-37156 |
|
| STAT1 deficiency supports PD1/PDL1 signaling resulting in dysfunctional TNFα mediated immune responses in a model of NSCLC |
|
https://doi.org/10.18632/oncotarget.26441
|
| 37157-37172 |
|
| Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapy |
|
https://doi.org/10.18632/oncotarget.26444
|
| 37173-37184 |
|
| Microenvironmentderived ADAM28 prevents cancer dissemination |
|
https://doi.org/10.18632/oncotarget.26449
|
| 37185-37199 |
|
| Payload of TDM1 binds to cell surface cytoskeletonassociated protein 5 to mediate cytotoxicity of hepatocytes |
|
https://doi.org/10.18632/oncotarget.26461
|
| 37200-37215 |
|
| Ybox binding protein YBX1 and its correlated genes as biomarkers for poor outcomes in patients with breast cancer |
|
https://doi.org/10.18632/oncotarget.26469
|
| 37216-37228 |
Reviews
|
| Extracellular vesicles: biomarkers and regulators of vascular function during extracorporeal circulation |
|
https://doi.org/10.18632/oncotarget.26433
|
| 37229-37251 |
|
| Cell penetrating peptides in preclinical and clinical cancer diagnosis and therapy |
|
https://doi.org/10.18632/oncotarget.26442
|
| 37252-37267 |
Corrections
|
| Correction: Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1 |
|
https://doi.org/10.18632/oncotarget.26488
|
| 37268-37268 |
|
| Correction: Oncogenomics of cMyc transgenic mice reveal novel regulators of extracellular signaling angiogenesis and invasion with clinical significance for human lung adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.26489
|
| 37269-37269 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
